Iron toxicity in neurodegeneration
Open accessThe DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Neuropathological stageing of Alzheimer-related changes.
Braak, H., & Braak, E. (1991) · Acta Neuropathologica · doi:10.1007/bf00308809 · Cited by 16,123
Cloning and characterization of a mammalian proton-coupled metal-ion transporter
Gunshin, H., Mackenzie, B., Berger, U. V., Gunshin, Y., Romero, M. F., Boron, W. F., Nussberger, S., Gollan, J. L., & Hediger, M. A. (1997) · Nature · doi:10.1038/41343 · Cited by 3,166 · cited 4×
“In the brain, DMT1 is expressed in hippocampal pyramidal and granule cells, cerebella granule cells, pyramidal cells of the piriform cortex, SN and the ventral portion of the anterior olfactory nucleus, striatum, cerebellum, hippocampus and thalamus, as well as in vascular cells throughout the brain and ependymal cell…”
BackgroundInfluentialThe ferritins: molecular properties, iron storage function and cellular regulation
Harrison, P. M., & Arosio, P. (1996) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/0005-2728(96)00022-9 · Cited by 2,667 · cited 2×
“The 24 subunits of ferritin form a hollow cavity that can store as many as 4,500 Fe atoms in the form of crystallized diferric oxo-hydroxyl complexes (Harrison and Arosio 1996).”
BackgroundMitochondrial Complex I Deficiency in Parkinson's Disease
Schapira, A. H. V., Cooper, J. M., Dexter, D., Clark, J. B., Jenner, P., & Marsden, C. D. (1990) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1990.tb02325.x · Cited by 2,283 · cited 1×
“MPTP is a potent inhibitor of complex I of the mitochondrial electron transport chain, through which inhibition produces the death of dopaminergic neuron of the SN (Schapira et al. 1990; Schapira and Gegg 2011).”
BackgroundIntracellular amyloid-β in Alzheimer's disease
LaFerla, F. M., Green, K. N., & Oddo, S. (2007) · Nature Reviews Neuroscience · doi:10.1038/nrn2168 · Cited by 1,942
Iron, brain ageing and neurodegenerative disorders
Zecca, L., Youdim, M. B. H., Riederer, P., Connor, J. R., & Crichton, R. R. (2004) · Nature Reviews Neuroscience · doi:10.1038/nrn1537 · Cited by 1,801
McKie, A. T., Marciani, P., Rolfs, A., Brennan, K., Wehr, K., Barrow, D., Miret, S., Bomford, A., Peters, T. J., Farzaneh, F., et al. (2000) · Molecular Cell · doi:10.1016/s1097-2765(00)80425-6 · Cited by 1,422
An iron-regulated ferric reductase associated with the absorption of dietary iron
McKie, A. T., Barrow, D., Latunde-Dada, G. O., Rolfs, A., Sager, G., Mudaly, E., Mudaly, M., Richardson, C., Barlow, D., Bomford, A., et al. (2001) · Science · doi:10.1126/science.1057206 · Cited by 1,101
DEXTER, D. T., CARAYON, A., JAVOY-AGID, F., AGID, Y., WELLS, F. R., DANIEL, S. E., LEES, A. J., JENNER, P., & MARSDEN, C. D. (1991) · Brain · doi:10.1093/brain/114.4.1953 · Cited by 1,043
Relationship of microglia and astrocytes to amyloid deposits of Alzheimer disease
Itagaki, S., McGeer, P. L., Akiyama, H., Zhu, S., & Selkoe, D. (1989) · Journal of Neuroimmunology · doi:10.1016/0165-5728(89)90115-x · Cited by 940
Iron-catalyzed hydroxyl radical formation. Stringent requirement for free iron coordination site.
Graf, E., Mahoney, J. R., Bryant, R. G., & Eaton, J. W. (1984) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)43139-5 · Cited by 855
Kakhlon, O., & Cabantchik, Z. I. (2002) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(02)01006-7 · Cited by 839 · cited 2×
“Once in the cytoplasm, Fe 2? becomes part of the labile or reactive iron pool where it distributes to mitochondria and ferritin or engages in electron exchange reactions (Kakhlon and Cabantchik 2002; Kruszewski 2003).”
BackgroundOhgami, R. S., Campagna, D. R., Greer, E. L., Antiochos, B., McDonald, A., Chen, J., Sharp, J. J., Fujiwara, Y., Barker, J. E., & Fleming, M. D. (2005) · Nature Genetics · doi:10.1038/ng1658 · Cited by 775
The Steap proteins are metalloreductases
Ohgami, R. S., Campagna, D. R., McDonald, A., & Fleming, M. D. (2006) · Blood · doi:10.1182/blood-2006-02-003681 · Cited by 744 · cited 7×
“Putative Fe 3? reductases include Dcytb, its homologous cytochrome b561, SDR2 and Steap2 (see text) Biometals (2012) 25:761–776 763 All the components described in Fig.”
BackgroundInfluentialMetals in Alzheimer's and Parkinson's Diseases
Barnham, K. J., & Bush, A. I. (2008) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2008.02.019 · Cited by 695 · cited 4×
“Considering that iron accumulates in the brain with age (Bartzokis et al. 1997; Barnham and Bush 2008), that major neurodegenerative disorders such as AD and Parkinson's disease are characterized by elevated tissue iron (Thompson et al. 2001; Collingwood et al. 2005; Collingwood et al. 2008;…”
BackgroundInfluentialMitoferrin is essential for erythroid iron assimilation
Shaw, G. C., Cope, J. J., Li, L., Corson, K., Hersey, C., Ackermann, G. E., Gwynn, B., Lambert, A. J., Wingert, R. A., Traver, D., et al. (2006) · Nature · doi:10.1038/nature04512 · Cited by 624 · cited 1×
“Iron is transported inside the mitochondria by the transporter mitoferrin (Shaw et al. 2006).”
BackgroundGenetic or Pharmacological Iron Chelation Prevents MPTP-Induced Neurotoxicity In Vivo
Kaur, D., Yantiri, F., Rajagopalan, S., Kumar, J., Mo, J. Q., Boonplueang, R., Viswanath, V., Jacobs, R., Yang, L., Beal, M. F., et al. (2003) · Neuron · doi:10.1016/s0896-6273(03)00126-0 · Cited by 620
Liuzzi, J. P., Lichten, L. A., Rivera, S., Blanchard, R. K., Aydemir, T. B., Knutson, M. D., Ganz, T., & Cousins, R. J. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0502257102 · Cited by 594 · cited 1×
“In mouse models, inflammatory stimuli like lipopolysaccharide (LPS) and turpentine induce upregulation of Zip14 through a mechanism involving IL-6 and induction of iNOS (Liuzzi et al. 2005).”
BackgroundCurtis, A. R. J., Fey, C., Morris, C. M., Bindoff, L. A., Ince, P. G., Chinnery, P. F., Coulthard, A., Jackson, M. J., Jackson, A. P., McHale, D. P., et al. (2001) · Nature Genetics · doi:10.1038/ng571 · Cited by 537 · cited 2×
“Lack of active ferritin can cause neurodegeneration, as found in hereditary neuroferritinopathy, a neurodegenerative disease characterized by the increase of iron and ferritin in the extracellular spaces and cytoplasm of cells in the basal ganglia of affected individuals (Curtis et al. 2001).”
BackgroundHirsch, E. C., Brandel, J. ‐., Galle, P., Javoy‐Agid, F., & Agid, Y. (1991) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1991.tb08170.x · Cited by 537 · cited 1×
“For experimental details of figures a, c and d see (Núñez et al., 2004) b of the SN pars compacta (Youdim et al. 1989; Hirsch et al. 1991; Gorell et al. 1995; Vymazal et al. 1999).”
BackgroundAlzheimer neuropathologic alterations in aged cognitively normal subjects
Davis, D. G., Schmitt, F. A., Wekstein, D. R., & Markesbery, W. R. (1999) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/00005072-199904000-00008 · Cited by 516 · cited 1×
“The finding that Ab-derived diffusible ligands promote tau phosphorylation suggests that tau pathology is secondary (Davis et al. 1999).”
BackgroundSalazar, J., Mena, N., Hunot, S., Prigent, A., Alvarez-Fischer, D., Arredondo, M., Duyckaerts, C., Sazdovitch, V., Zhao, L., Garrick, L. M., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0804373105 · Cited by 409
Self-citationConnor, J. R., Snyder, B. S., Beard, J. L., Fine, R. E., & Mufson, E. J. (1992) · Journal of Neuroscience Research · doi:10.1002/jnr.490310214 · Cited by 374 · cited 2×
“…globally decreased in the brain of AD subjects and instead of being in its regular location in oligodendrocytes, it appears to be sequestered in SP (Connor et al. 1992); Tf receptor is highly expressed in the neocortex and hippocampus of AD brains but localized to capillary endothelium with only a…”
BackgroundMolecular control of vertebrate iron homeostasis by iron regulatory proteins
Wallander, M. L., Leibold, E. A., & Eisenstein, R. S. (2006) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2006.05.004 · Cited by 287
Shachar, D. B., Kahana, N., Kampel, V., Warshawsky, A., & Youdim, M. B. H. (2004) · Neuropharmacology · doi:10.1016/j.neuropharm.2003.09.005 · Cited by 246
Ferroportin‐mediated mobilization of ferritin iron precedes ferritin degradation by the proteasome
De Domenico, I., Vaughn, M. B., Li, L., Bagley, D., Musci, G., Ward, D. M., & Kaplan, J. (2006) · The EMBO Journal · doi:10.1038/sj.emboj.7601409 · Cited by 235 · cited 1×
“Although ferritin is expected to reduce this pool by storing iron, there is a dynamic exchange of iron between its ferritin-bound form and a cytoplasmic form amenable to transport by FPN1 (De Domenico et al. 2006).”
BackgroundIron and neurodegenerative disorders
Thompson, K. J., Shoham, S., & Connor, J. R. (2001) · Brain Research Bulletin · doi:10.1016/s0361-9230(01)00510-x · Cited by 235 · cited 2×
“1997; Barnham and Bush 2008), that major neurodegenerative disorders such as AD and Parkinson’s disease are characterized by elevated tissue iron (Thompson et al. 2001; Collingwood et al. 2005; Collingwood et al. 2008; Barnham and Bush 2008) and that excess iron is a strong promoter of oxidative stress, it is of relev…”
BackgroundYOUDIM, M. B. H., STEPHENSON, G., & SHACHAR, D. B. (2004) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1306.025 · Cited by 233 · cited 2×
“…dopamine (another inhibitor of complex I) intoxication is prevented by the pharmacologic or genetic chelation of iron (Kaur et al. 2003; Shachar et al. 2004; Youdim et al. 2004; Youdim and Buccafusco 2005; Zheng et al. 2010) or by dysfunction of the iron transporter DMT1 (Salazar et al. 2008).”
BackgroundIron in the basal ganglia in Parkinson's disease
Griffiths, P. D., Dobson, B. R., Jones, G. R., & Clarke, D. T. (1999) · Brain · doi:10.1093/brain/122.4.667 · Cited by 229
Iron loading and erythrophagocytosis increase ferroportin 1 (FPN1) expression in J774 macrophages
Knutson, M. D., Vafa, M. R., Haile, D. J., & Wessling-Resnick, M. (2003) · Blood · doi:10.1182/blood-2003-04-1250 · Cited by 227
The Role of Iron in Neurodegeneration: Prospects for Pharmacotherapy of Parkinson??s Disease
Jellinger, K. A. (1999) · Drugs & Aging · doi:10.2165/00002512-199914020-00004 · Cited by 218 · cited 3×
“…include Parkinson's disease, Alzheimer's disease, Huntington's disease, Friedreich's ataxia, neuroferritinopathy and Amyotrophic Lateral Sclerosis (Jellinger 1999; Bartzokis et al. 2000; Sayre et al. 2000; Perry et al. 2003; Zecca et al. 2004; Berg and Youdim 2006; Wilson 2006; Weinreb et al.…”
BackgroundRegulation of reticuloendothelial iron transporter MTP1 (Slc11a3) by inflammation
Yang, F., Liu, X.-B., Quinones, M., Melby, P. C., Ghio, A., & Haile, D. J. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m201485200 · Cited by 197 · cited 1×
“FPN1 has an IRE motif in the 5 0 -UTR of its mRNA that bestows on FPN1 a ferritin-like response to variations in cell iron, increasing its expression under elevated iron conditions (McKie et al. 2000; Yang et al. 2002; Aguirre et al. 2005).”
BackgroundIron: The Redox-active Center of Oxidative Stress in Alzheimer Disease
Castellani, R. J., Moreira, P. I., Liu, G., Dobson, J., Perry, G., Smith, M. A., & Zhu, X. (2007) · Neurochemical Research · doi:10.1007/s11064-007-9360-7 · Cited by 180 · cited 2×
“reported in brain regions affected by neurodegeneration (Connor and Benkovic 1992; Castellani et al. 2007).”
BackgroundIn Vivo Magnetic Resonance Microimaging of Individual Amyloid Plaques in Alzheimer's Transgenic Mice
Jack, C. R., Wengenack, T. M., Reyes, D. A., Garwood, M., Curran, G. L., Borowski, B. J., Lin, J., Preboske, G. M., Holasek, S. S., Adriany, G., et al. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.2588-05.2005 · Cited by 148
Collingwood, J. F., Chong, R. K. K., Kasama, T., Cervera-Gontard, L., Dunin-Borkowski, R. E., Perry, G., Pósfai, M., Siedlak, S. L., Simpson, E. T., Smith, M. A., et al. (2008) · Journal of Alzheimer's Disease · doi:10.3233/jad-2008-14211 · Cited by 147 · cited 2×
“1997; Barnham and Bush 2008), that major neurodegenerative disorders such as AD and Parkinson’s disease are characterized by elevated tissue iron (Thompson et al. 2001; Collingwood et al. 2005; Collingwood et al. 2008; Barnham and Bush 2008) and that excess iron is a strong promoter of oxidative stress, it is of relev…”
BackgroundCorrelation of iron in the hippocampus with MMSE in patients with Alzheimer's disease
Ding, B., Chen, K., Ling, H., Sun, F., Li, X., Wan, T., Chai, W., Zhang, H., Zhan, Y., & Guan, Y. (2009) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.21730 · Cited by 129 · cited 1×
“As with NFT, hippocampal iron accumulation in AD subjects (evaluated by gradient-echo MRI) correlates well with cognitive decline assessed by the minimental state examination performance (Ding et al. 2009).”
BackgroundIron-regulatory proteins: molecular biology and pathophysiological implications
Cairo, G., & Recalcati, S. (2007) · Expert Reviews in Molecular Medicine · doi:10.1017/s1462399407000531 · Cited by 124
Faucheux, B. A., Martin, M., Beaumont, C., Hunot, S., Hauw, J., Agid, Y., & Hirsch, E. C. (2002) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2002.01118.x · Cited by 116 · cited 3×
“The reasons for this low ferritin expression is unknown, but it could be due to increased Iron regulatory protein 1 (IRP1) activity (Faucheux et al. 2002).”
BackgroundCozzi, A., Santambrogio, P., Corsi, B., Campanella, A., Arosio, P., & Levi, S. (2006) · Neurobiology of Disease · doi:10.1016/j.nbd.2006.05.004 · Cited by 38
Gerlach, M., Riederer, P., & Double, K. L. (2008) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2008.04.028 · Cited by 33
Cited by
The Role of Oxidative Stress in Parkinson's Disease
Dias, V., Junn, E., & Mouradian, M. M. (2013) · Journal of Parkinson’s Disease · doi:10.3233/jpd-130230 · Cited by 1,845
Quantitative susceptibility mapping (QSM): Decoding MRI data for a tissue magnetic biomarker
Wang, Y., & Liu, T. (2015) · Magnetic Resonance in Medicine · doi:10.1002/mrm.25358 · Cited by 878
Oxidative Stress and Antioxidants in Neurodegenerative Disorders
Olufunmilayo, E. O., Gerke-Duncan, M. B., & Holsinger, R. M. D. (2023) · Antioxidants · doi:10.3390/antiox12020517 · Cited by 670
Metals, oxidative stress and neurodegeneration: A focus on iron, manganese and mercury
Farina, M., Avila, D. S., da Rocha, J. B. T., & Aschner, M. (2013) · Neurochemistry International · doi:10.1016/j.neuint.2012.12.006 · Cited by 553
Iron and neurodegeneration in the multiple sclerosis brain
Hametner, S., Wimmer, I., Haider, L., Pfeifenbring, S., Brück, W., & Lassmann, H. (2013) · Annals of Neurology · doi:10.1002/ana.23974 · Cited by 519
Metadata
- Authors
- Núñez, M. T., Urrutia, P., Mena, N., Aguirre, P., Tapia, V., & Salazar, J.
- Venue
- BioMetals
- Published
- 2012-02-09
- Volume
- 25
- Issue
- 4
- Pages
- 761-776
- ISSN
- 0966-0844 (ISSN-L)
- 1572-8773
- OpenAlex
- W2008727814
- Cited by
- 180
- References
- 40
- FWCI
- 10.95
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.